Welcome to another Friday episode! Today, I dive into a crucial aspect for both personal and organizational success: setting clear goals. Whether you lead a team, department, or work as an individual contributor, having a well-defined vision and goals is paramount. But have you ever wondered why some people come
In this new episode, Guillaume Desachy and I dive into the world of R and its impact on the pharmaceutical industry. Guillaume, a Statistical Science Director at AstraZeneca in Sweden, shares his insights and experiences in fostering an R community within the company. Embarking on the exploration of Guillaume’s journey
In the ever-evolving landscape of professional development, I’ve noticed that the term “strategy” is frequently thrown around, often without a clear understanding of its true meaning. Unfortunately, this misunderstanding often leads to the formulation of ineffective strategies, a topic explored by Richard Rumelt in his book Good Strategy/Bad Strategy. In
Ever wondered about the intricate connections between observational studies and the Estimand framework in the pharmaceutical industry? How do the challenges in multi-country primary data collection unfold, and what crucial role do assumptions play in propensity score methods? In this captivating episode, I’m excited to have Artemis Koukounari, an accomplished
This time, I’m engaging in a conversation with Katharina, and I must say I’m thrilled to explore more on the topic of ethical statistics. In our previous discussion, we delved into the importance of ethical guidelines, particularly focusing on the ISI declaration of Ethics. Today, we aim to take things
Today, I am excited to share profound insights where I delve deep into the art of sketching my career path and crafting a strategic plan for success. I find myself in a quaint hotel room in the UK, surrounded by the historical charm of my surroundings, and recording in this
This is an extraordinary episode that takes us deep into the world of modern pharmaceutical research. Today, we are embarking on a captivating journey guided by the insightful dialogue between Elena Polverejan and me. Throughout this episode, we uncover the potential of the Estimands Framework. Join us as we delve
I’m thrilled to dive into a topic that has been untouched in the past 300 episodes – crossover studies. It’s a classical design that offers unique advantages, yet it’s often overlooked. Joining me today is Markus Savli, a biostatistician with a diverse background in biomedical engineering, mathematics, and epidemiology. Together,
In the intricate world of statistics organizations, a common challenge often arises: how to balance increasing cost pressures while maintaining the quality and relevance of the produced tables. In this episode, I dive into this recurring scene, shedding light on the art of negotiation on the numbers of tables. I
In today’s episode, I discuss the crucial topic of risk management in clinical trials with guest Jess Thompson. Jess, the founder of the Association of Clinical Research Project Managers, shares her extensive experience in the field, emphasizing the importance of proactive risk identification and collaborative communication within project teams. The
In this episode, I interview Katharina Schueller, a statistician and entrepreneur, to discuss the importance of ethical guidelines for statisticians. Katharina shares her insights on the ethical aspects of statistics, the responsibilities of statisticians, and the relevance of the Declaration of Ethics by the International Statistics Institute (ISI). We explore
The modern working environment is defined by endless to-do lists, tight deadlines, and the expectation to do more with less. As employees struggle to manage the job responsibilities of 2 or 3 people, exhaustion happens first. Long working hours, with little to no downtime, lead to mental and physical fatigue.
Never miss an episode of The Effective Statistician
Join hundreds of your peers and subscribe to get our latest updates by email!